My Portfolio
+
LINK YOUR PORTFOLIO

Halozyme Therapeutics Inc HALO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:15 PM EDT
69.59quote price arrow down-0.23 (-0.33%)
Volume
68,445
Close
69.82quote price arrow up+3.54 (+5.34%)
Volume
2,075,127
52 week range
51.06 - 82.22
Loading...
  • Open66.00
  • Day High70.13
  • Day Low66.00
  • Prev Close66.28
  • 52 Week High82.22
  • 52 Week High Date02/09/26
  • 52 Week Low51.06
  • 52 Week Low Date06/30/25

Latest On Halozyme Therapeutics Inc

 

Key Stats

  • Market Cap8.282B
  • Shares Out118.61M
  • 10 Day Average Volume1.77M
  • Dividend-
  • Dividend Yield-
  • Beta0.87

Latest On Halozyme Therapeutics Inc

 

KEY STATS

  • Open66.00
  • Day High70.13
  • Day Low66.00
  • Prev Close66.28
  • 52 Week High82.22
  • 52 Week High Date02/09/26
  • 52 Week Low51.06
  • 52 Week Low Date06/30/25
  • Market Cap8.282B
  • Shares Out118.61M
  • 10 Day Average Volume1.77M
  • Dividend-
  • Dividend Yield-
  • Beta0.87

RATIOS/PROFITABILITY

  • EPS (TTM)2.78
  • P/E (TTM)25.11
  • Fwd P/E (NTM)7.93
  • EBITDA (TTM)960.652M
  • ROE (TTM)99.40%
  • Revenue (TTM)1.508B
  • Gross Margin (TTM)82.79%
  • Net Margin (TTM)23.13%
  • Debt To Equity (MRQ)976.45%

EVENTS

  • Earnings Date08/03/2026(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Halozyme Therapeutics, Inc. is a biopharmaceutical company advancing solutions to improve patient experiences and outcomes for emerging and established therapies. The Company's commercially-validated solution, ENHANZE drug delivery technology with the proprietary enzyme rHuPH20, is used to facilitate the subcutaneous delivery of injected drugs and fluids, with a focus on improving the patient experience with rapid subcutaneous delivery and reduced treatment burden. The...
Jeffrey Henderson
Independent Chairman of the Board
Helen Torley
President, Chief Executive Officer, Director
Cortney Caudill
Chief Operating Officer, Senior Vice President
David Ramsay
Interim Chief Financial Officer
Address
12390 EL CAMINO REAL
San Diego, CA
92130
United States